Case and Research Letter
Efficacy and Safety of Omalizumab in a Patient With Chronic Spontaneous Urticaria and Active Hepatitis B Virus Infection
Eficacia y seguridad de omalizumab en un paciente con urticaria crónica espontánea e infección activa por el virus de la hepatitis B
P. Chicharro
, P. Rodríguez-Jiménez, D. de Argila
Corresponding author
Servicio de Dermatología, Hospital Universitario de La Princesa, Madrid, España
Read
7554
Timeswas read the article
2344
Total PDF
5210
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 66 | 14 | 80 |
| 2025 5 | 224 | 40 | 264 |
| 2025 4 | 200 | 43 | 243 |
| 2025 3 | 150 | 24 | 174 |
| 2025 2 | 168 | 36 | 204 |
| 2025 1 | 136 | 45 | 181 |
| 2024 12 | 134 | 41 | 175 |
| 2024 11 | 134 | 66 | 200 |
| 2024 10 | 105 | 45 | 150 |
| 2024 9 | 112 | 46 | 158 |
| 2024 8 | 132 | 75 | 207 |
| 2024 7 | 110 | 34 | 144 |
| 2024 6 | 129 | 40 | 169 |
| 2024 5 | 149 | 45 | 194 |
| 2024 4 | 126 | 43 | 169 |
| 2024 3 | 89 | 44 | 133 |
| 2024 2 | 71 | 34 | 105 |
| 2024 1 | 79 | 29 | 108 |
| 2023 12 | 87 | 21 | 108 |
| 2023 11 | 95 | 26 | 121 |
| 2023 10 | 83 | 18 | 101 |
| 2023 9 | 98 | 25 | 123 |
| 2023 8 | 44 | 15 | 59 |
| 2023 7 | 71 | 28 | 99 |
| 2023 6 | 83 | 28 | 111 |
| 2023 5 | 60 | 21 | 81 |
| 2023 4 | 64 | 29 | 93 |
| 2023 3 | 63 | 32 | 95 |
| 2023 2 | 47 | 29 | 76 |
| 2023 1 | 68 | 38 | 106 |
| 2022 12 | 91 | 36 | 127 |
| 2022 11 | 32 | 35 | 67 |
| 2022 10 | 29 | 22 | 51 |
| 2022 9 | 24 | 45 | 69 |
| 2022 8 | 44 | 49 | 93 |
| 2022 7 | 37 | 45 | 82 |
| 2022 6 | 24 | 25 | 49 |
| 2022 5 | 48 | 47 | 95 |
| 2022 4 | 40 | 49 | 89 |
| 2022 3 | 69 | 70 | 139 |
| 2022 2 | 50 | 32 | 82 |
| 2022 1 | 69 | 39 | 108 |
| 2021 12 | 49 | 46 | 95 |
| 2021 11 | 46 | 44 | 90 |
| 2021 10 | 53 | 54 | 107 |
| 2021 9 | 45 | 30 | 75 |
| 2021 8 | 48 | 28 | 76 |
| 2021 7 | 39 | 28 | 67 |
| 2021 6 | 55 | 35 | 90 |
| 2021 5 | 58 | 49 | 107 |
| 2021 4 | 116 | 69 | 185 |
| 2021 3 | 71 | 23 | 94 |
| 2021 2 | 76 | 23 | 99 |
| 2021 1 | 33 | 19 | 52 |
| 2020 12 | 28 | 20 | 48 |
| 2020 11 | 34 | 25 | 59 |
| 2020 10 | 38 | 13 | 51 |
| 2020 9 | 50 | 22 | 72 |
| 2020 8 | 30 | 19 | 49 |
| 2020 7 | 35 | 14 | 49 |
| 2020 6 | 28 | 36 | 64 |
| 2020 5 | 14 | 9 | 23 |
| 2020 4 | 35 | 20 | 55 |
| 2020 3 | 32 | 13 | 45 |
| 2020 2 | 7 | 0 | 7 |
| 2019 12 | 4 | 0 | 4 |
| 2019 11 | 4 | 0 | 4 |
| 2019 9 | 7 | 0 | 7 |
| 2019 8 | 8 | 0 | 8 |
| 2019 7 | 7 | 0 | 7 |
| 2019 6 | 4 | 0 | 4 |
| 2019 5 | 5 | 0 | 5 |
| 2019 4 | 20 | 2 | 22 |
| 2019 3 | 3 | 0 | 3 |
| 2019 2 | 5 | 0 | 5 |
| 2019 1 | 3 | 0 | 3 |
| 2018 12 | 9 | 0 | 9 |
| 2018 11 | 14 | 0 | 14 |
| 2018 10 | 4 | 2 | 6 |
| 2018 9 | 6 | 0 | 6 |
| 2018 2 | 25 | 7 | 32 |
| 2018 1 | 43 | 14 | 57 |
| 2017 12 | 24 | 12 | 36 |
| 2017 11 | 32 | 10 | 42 |
| 2017 10 | 26 | 10 | 36 |
| 2017 9 | 28 | 14 | 42 |
| 2017 8 | 40 | 10 | 50 |
| 2017 7 | 19 | 10 | 29 |
| 2017 6 | 49 | 9 | 58 |
| 2017 5 | 57 | 31 | 88 |
| 2017 4 | 10 | 26 | 36 |
Show all
